Skip to main content

Table 4 TC, IC and CPS of tissue samples of the index patients before and after nivolumab therapy

From: Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

Type squamous component 28–8 22C3 SP263 SP142
IC% TC% CPS IC% TC% CPS IC% TC% CPS IC% TC% CPS
TUR-B 82 months 80% 30 1 30 30 1 30 25 7 30 7 0 7
Cystx 101 months 15% 10 0 10 10 0 10 10 0 10–12 7 0 7